Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19.
Cleve Clin J Med
; 87(11): 659-663, 2020 11 02.
Article
in English
| MEDLINE | ID: covidwho-908366
ABSTRACT
In COVID-19, respiratory infection with SARS-CoV-2 plus another virus (viral co-infection) or with SARS-CoV-2 plus a bacterial pathogen (combined viral and bacterial pneumonia) has been described. Secondary bacterial pneumonia can follow the initial phase of viral respiratory infection or occur during the recovery phase. No obvious pattern or guidelines exist for viral co-infection, combined viral and bacterial pneumonia, or secondary bacterial pneumonia in COVID-19. Based on existing clinical data and experience with similar viruses such as influenza and SARS-CoV, the management approach in COVID-19 should, ideally, take into consideration the overall presentation and the trajectory of illness.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Patient Care Management
/
Virus Diseases
/
Coronavirus Infections
/
Pneumonia, Bacterial
/
Pandemics
/
Coinfection
/
Anti-Bacterial Agents
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Cleve Clin J Med
Journal subject:
Medicine
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS